191 related articles for article (PubMed ID: 16897986)
1. [S-1 as a single agent for colorectal cancer].
Eguchi T; Shirao K
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():121-4. PubMed ID: 16897986
[TBL] [Abstract][Full Text] [Related]
2. [S-1 for gastric cancer-S-1 monotherapy and its progress].
Shitara K; Sakata Y; Kudou T; Munakata M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():43-51. PubMed ID: 16897971
[TBL] [Abstract][Full Text] [Related]
3. [The current evidence of S-1 and irinotecan hydrochloride combination chemotherapy with tri-weekly schedule].
Goto A
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():125-30. PubMed ID: 16897987
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy with S-1 plus CPT-11 for patients with advanced or recurrent colorectal cancer].
Tsunoda A; Nakao K; Kamiyama G; Narita K; Yamazaki K; Watanabe M; Suzuki N; Oonaka T; Kusano M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():135-7. PubMed ID: 16897989
[TBL] [Abstract][Full Text] [Related]
5. [Clinical benefit of S-1 in metastatic breast cancer].
Saeki T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():202-6. PubMed ID: 16898003
[TBL] [Abstract][Full Text] [Related]
6. [Controversy of treatment for advanced colorectal cancer--intermedisine].
Sato A; Shimada K; Taguchi S
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1260-9. PubMed ID: 14518404
[TBL] [Abstract][Full Text] [Related]
7. [Progress in chemotherapy for colorectal cancer].
Sasaki T; Maeda Y
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2185-92. PubMed ID: 11142161
[TBL] [Abstract][Full Text] [Related]
8. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
[TBL] [Abstract][Full Text] [Related]
9. [Current evidence of irinotecan combination chemotherapy with TS-1 in patients with advanced colorectal cancer].
Goto A
Gan To Kagaku Ryoho; 2006 Jul; 33(7):896-900. PubMed ID: 16835475
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group.
Ohtsu A; Baba H; Sakata Y; Mitachi Y; Horikoshi N; Sugimachi K; Taguchi T
Br J Cancer; 2000 Jul; 83(2):141-5. PubMed ID: 10901361
[TBL] [Abstract][Full Text] [Related]
11. [Combination chemotherapy with S-1 and cisplatin for non-small cell lung cancer].
Wataya H; Ichinose Y
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():194-6. PubMed ID: 16898001
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of S-1 monotherapy in patients with metastatic colorectal cancer after failure to fluoropyrimidine and irinotecan or to fluoropyrimidine, irinotecan and oxaliplatin.
Yasui H; Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamazaki K; Taku K; Kojima T; Machida N
Jpn J Clin Oncol; 2009 May; 39(5):315-20. PubMed ID: 19403734
[TBL] [Abstract][Full Text] [Related]
13. Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
Chu QS; Hammond LA; Schwartz G; Ochoa L; Rha SY; Denis L; Molpus K; Roedig B; Letrent SP; Damle B; DeCillis AP; Rowinsky EK
Clin Cancer Res; 2004 Aug; 10(15):4913-21. PubMed ID: 15297391
[TBL] [Abstract][Full Text] [Related]
14. Anticancer activity and toxicity of S-1, an oral combination of tegafur and two biochemical modulators, compared with continuous i.v. infusion of 5-fluorouracil.
Fukushima M; Shimamoto Y; Kato T; Uchida J; Yonekura R; Ohshimo H; Shirasaka T
Anticancer Drugs; 1998 Oct; 9(9):817-23. PubMed ID: 9840729
[TBL] [Abstract][Full Text] [Related]
15. [Irinotecan plus oral S-1 in patients with advanced colorectal cancer--biweekly IRIS regimen].
Komatsu Y; Yuki S; Tateyama M; Kudo M; Asaka M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():131-4. PubMed ID: 16897988
[TBL] [Abstract][Full Text] [Related]
16. Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.
Ajani JA
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():117-20. PubMed ID: 16897985
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of S-1 in colorectal cancer.
Miyamoto Y; Sakamoto Y; Yoshida N; Baba H
Expert Opin Pharmacother; 2014 Aug; 15(12):1761-70. PubMed ID: 25032886
[TBL] [Abstract][Full Text] [Related]
18. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577
[TBL] [Abstract][Full Text] [Related]
19. A phase I trial of CPT-11 and S-1 combination chemotherapy in patients with metastatic colorectal cancer.
Yamaguchi Y; Minami K; Kawabuchi Y; Ohshita A; Hironaka K
Hepatogastroenterology; 2008; 55(82-83):407-11. PubMed ID: 18613376
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous continuous infusion of fluorouracil for treatment of metastatic colorectal cancer].
Hosokawa A
Nihon Rinsho; 2003 Sep; 61 Suppl 7():352-5. PubMed ID: 14574911
[No Abstract] [Full Text] [Related]
[Next] [New Search]